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Intima-media thickness of common carotid and brachial arteries and 
prothrombin fragment 1+2 are associated with diastolic dysfunction in 
patients with myocardial infarction 
Aims: To investigate the association between intima-media thickness of brachial and common 
carotid arteries and factors of the coagulation- and fibrinolysis system with diastolic 
dysfunction in patients with a previous myocardial infarction. 
Patients and methods: One hundred and five patients, men (72 %) and women (28%) aged 
between 32-73 years with a history of previous acute myocardial infarction were included. An 
age-matched control group with no cardiovascular risk factors was used as a comparison. B-
mode ultrasound of common carotid and brachial arteries and echocardiography were 
evaluated in all subjects. Calculated intima-media area (cIMa) of the common carotid and 
brachial arteries and tissue Doppler imaging (TDI) were examined. Factors of the 
coagulation- and fibrinolysis system were also measured. 
 Results: Prothrombin fragment 1+2 was significantly higher in patients with previous 
myocardial infarction compared to the control group (P<0.01). Early diastolic filling peak 
velocity (E´-v) and late diastolic filling peak velocity (A´-v) was significantly lower among 
patients with previous myocardial infarction than in the control group (P<0.01 respectively 
P<0.001). Late diastolic filling peak time was significantly and positively associated with log 
Prothrombin fragment 1+2 (P<0.001), calculated common carotid cIMa (P<0.02), systolic 
blood pressure (P<0.01) and to IMT of brachial artery (P<0.02) in patients with a previous 
MI. In stepwise multiple regression analysis, log Prothrombin fragment 1+2 remained the only 
variable with independent significant correlation to late diastolic filling peak time. 
Conclusions:  Diastolic dysfunction is correlated to cIMa of common carotid and brachial 
arteries, systolic blood pressure and Prothrombin fragment 1+2 in patients with myocardial 
infarction. Thus, atherosclerosis, diastolic dysfunction and coagulopathy are tightly 
interrelated disorders in patients with myocardial infarction.  
Introduction 
 
Tissue Doppler imaging (TDI) is a well-established ultrasound technique. TDI is suitable 
measuring left ventricle diastolic and systolic function in different pathologies1,2.  Left 
ventricular diastolic function has been shown to be an important predictor of morbidity and 
mortality after acute myocardial infarction3.  
Thrombin is considered having a central role in the pathophysiology of cardiovascular 
disease4. A crucial event in the coagulation cascade is the conversion of prothrombin to 
thrombin. Prothrombin fragment 1+2 is a polypeptide released from the prothrombin during 
this transfer. Measurement of circulating levels of prothrombin fragment 1+2 has been 
regarded as an indicator of thrombin generation in vivo5,6. Previous studies have indicated that 
prothrombin fragment 1+2 levels are predictors of major coronary events7-10. Other studies 
have failed to show a relationship between prothrombin fragment 1+2 and coronary heart 
disease11,12.  
 
Intima-media thickness (IMT) of the carotid arteries is an indicator of a subclinical 
atherosclerosis which, in previous studies, has been shown to predict the incidence of 
cardiovascular disease13-15.  
Indications that thrombin generation may have an unfavorable effect on the thickening of the 
arterial wall in subjects free of clinical cardiovascular disease has been reported16. 
 
The aim of this study was to examine the relationship between late diastolic filling peak time 
and factors of the coagulation- and fibrinolysis system, cIMa of the common carotid and 
brachial arteries in patients with a previous history of myocardial infarction.   
 
METHODS 
 Subjects 
One hundred and five patients, men (72 %) and women (28%) aged between 32-73 years with 
a history of previous acute myocardial infarction were included. The patients were recruited 
from the department of Cardiology at Karolinska University Hospital Huddinge, Sweden. A 
majority of the patients were recruited at the post CCU, 2-3 days after the myocardial 
infarction. The examinations of this study were performed 1-12 months after the index event. 
Ninety percent of the patients in this study were examined 3 months after the myocardial 
infarction. The control group consisted of ten male volunteers aged between 36-71 years.  
The exclusion criterion was known diabetes mellitus. Only patients with previously well-
known and established diabetes were excluded. All subjects gave informed consent after 
written and oral information. The ethics committee of the Karolinska Institute at Karolinska 
University Hospital Huddinge approved the study.  
 
Acute myocardial infarction was defined using the criteria of the European Society of 
Cardiology and the American College of Cardiology 17. Thus, patients were diagnosed as 
having an acute myocardial infarction if they had two values of serum troponin T greater than 
0.05 g/L together with either typical symptoms or new Q-waves in at least two of the twelve 
standard electrocardiographic leads, or electrocardiogram changes indicating acute ischemia 
(ST-elevation, ST-depression, or T-wave inversion).  
 
Measurements 
Venous blood was drawn after an overnight fast and 5 min of supine rest for determination of 
serum levels of cholesterol, triglycerides and fasting plasma glucose using established 
methods. Venous blood was also drawn with minimal cuff pressure for analysing the 
hemostatic markers including fibrinogen, von Willebrand factor, Plasminogen activator 
inhibitor 1 ( PAI-1) and prothrombin fragment 1+2. The citrated blood samples were 
centrifuged within 30 minutes, and plasma was immediately frozen in aliquots and stored at - 
70°C until analysis. PAI- 1 activity was determined by using the Spectrolyze PAI-1 kit 
(Biopool AB) on the citrated plasma samples that had been stored at - 70°C. Von Willebrand 
factor antigen was measured by a commercially available ELISA method (Liatest® vWF kit, 
Stago provided by Triolab AB). Fibrinogen levels in plasma were determined by conventional 
techniques (Sysmex CA-1500). Level of prothrombin fragment 1+2 was assessed by using 
enzyme-linked immunosorbent assay kits, Enzygnost F1+2 (Behring). 
Resting blood pressure was measured in the right arm after about 10 min supine rest. Body 
mass index (BMI) was calculated as weight divided by height squared (kg/m²). 
Smoking status was assessed by a questionnaire.   
 Tissue Doppler imaging echocardiography 
All studied individuals were examined with echocardiography and TDI using a GE Vingmed 
System FiVe (Horten, Norway). A standard phased array 2.5 MHz multifrequency transducer 
was used. All recordings were performed at the end of expiration from apical four chambers 
(4CH) and two chamber (2CH) view with the subjects in left lateral position. Cine loops of 
two consecutive heartbeats were acquired in each case with a high temporal resolution (90-
147 frames/s, mean 113). The formatted raw data containing both grey scale and TDI 
information were stored as IQ-data on magneto-optical disk and then transferred to a 
Macintosh computer for off-line analysis employing the commercially available software 
Echopac version 6.3.6 (GE Vingmed). The TDI analysis was performed from an optimal 
measuring position set at the basal segment of each wall (septum, lateral, inferior and anterior 
wall) of the left ventricle, depending on image characteristics. The true isovolumic 
contraction period was established in separate experiments by defining off-line in apical five 
chamber (5CH) view the time point for the closure of the mitral valve and the opening of the 
aortic valve using anatomical M-mode in 2D grey scale images from two consecutive 
heartbeats. The true isovolumic relaxation period was defined similarly by aortic closure and 
mitral valve opening. Anatomical colour M-mode extracted from TDI and the myocardial 
tissue velocity profile from the basal septum were recorded for the same heartbeats. The grey 
scale anatomical M-mode images of the mitral and aortic valve and colour anatomical M-
mode images and velocity profiles from the basal septum were then organised and 
synchronised according to ECG signal using  Microsoft® Power Point for Windows version 
9.0. The following variables in the tissue velocity curve were measured. 
Isovolumic contraction time (IVCT): A period of time between the zero crossing point for the 
ascending limb of the positive isovolumic velocity wave and the zero crossing point for the 
ascending limb of the myocardial tissue velocity curve at the beginning of the systolic 
ejection. During this period of time the tissue velocity profile usually shows biphasic pattern 
of motion, i.e. a positive deflection followed by a negative wave but single-phase movements 
(positive or negative) may occur as well. In some of these cases, the zero crossing reference 
points were not available and the beginning and the end of IVCT were defined using the 
anatomical M-mode images of the closure of the mitral and the opening of the aortic valve.  
 Isovolemic relaxation time (IVRT): A period of time between the zero crossing point for the 
descending limb of the systolic myocardial tissue velocity curve at the end of the systolic 
ejection and the zero crossing point for the one-phase (ascending or descending) or two-phase 
tissue velocity curve at the start of the diastolic E'-wave. During this period of time the tissue 
velocity profile usually shows two-phase tissue motion, i.e. a negative deflection followed by 
a positive wave but single-phase movements (positive or negative) may occur as well. If the 
zero crossing reference points could not be established, IVRT was defined using the 
anatomical M-mode images of the aortic closure and the opening of the mitral valve. Only in 
3 of 105 investigated patients the zero point was not clearly identified and anatomical M-
mode images were used to identify IVRT and IVCT. The myocardial performance index ( 
MPI) was calculated off-line according to the equation (IVRT + IVCT)/ LV ejection time. 
The intra-observer variability for different systolic and diastolic parameters in the velocity 
profile varied between 5 and 10%, as described earlier18.  
Echocardiography  
All patients underwent a standard echocardiographic evaluation, using a 2.5 MHz transducer 
(System Five, GE Vingmed, Horten, Norway). The echocardiographic studies were performed 
with the subject in left lateral decubitus, position. One physician unaware of the other patient 
data recorded all the echocardiograms. Left ventricular internal dimension and interventricular 
septum thickness and ejection fraction were measured according the recommendations of the 
American Society of Echocardiography 19. The motion of the AV-plane was assed from the 
four-chamber apical view, using M-mode as described previously20. 
Carotid B-mode ultrasonography 
The right and left carotid arteries were examined with a duplex scanner (Aspen, Acuson, 
Mountain View, Ca, USA) by using a 7 MHz linear array transducer. The same trained 
sonographer performed all scannings. The far wall of the common carotid artery (CCA), 0,5 
to 1,0 cm proximal to the beginning of the carotid bulb, was used for measurements of the 
IMT and lumen diameter. The examinations were video taped for subsequent analyses by a 
computer system21 with automated tracing of echo interfaces and measurements of distances 
between the wall echoes within a 10 mm long section of CCA in late diastole, defined by a 
simultaneous electrocardiographic recording. The mean values of the IMT and lumen 
diameter within the 10 mm long section were calculated. The differences between repeated 
measurements of IMT and lumen diameter, by using the automated analysing system, were 
3.2 % and 0.6 % (coefficient of variation), respectively (with an IMT of 0.48 to 1.04 mm and 
a lumen diameter of 4,34 to 7,91 mm). To compensate for the stretching effect of arterial 
distension (secondary to increased arterial pressure) on the wall thickness, the cross-sectional 
intima-media area was calculated by using the formula 3.14 [(lumen diameter/2 + intima-
media thickness)2- (lumen diameter/2)2]. This calculated intima-media area (cIMa), but not 
the IMT, has been shown to be unaffected by variations in artery distension secondary to 
changes in blood pressure22. The ultrasonographic methods used have been described in detail 
previously23,24. 
Brachial B-mode ultrasonography 
The ultrasound procedures for assessing IMT of brachial artery were performed as described 
in the international guidelines by Corretti et al25. The patients were examined in the morning 
after fasting since midnight. The patients were told not to use long-acting nitroglycerin or 
calcium channel blockers drugs 36 hours before the examination. A high-resolution 
ultrasound scanner (System Five, GE Vingmed, Horten, Norway) with a 10.0-MHz linear 
array transducer was used. After 10-minute equilibration period at rest in the recumbent 
position, a single dedicated ultrasonographer performed measurements of the left brachial 
artery. Scans of the brachial artery were taken proximal to the antecubital fossa and saved on 
videotape.Images were digitally acquired from the videotape and measured in random order 
by a single observer blinded to the conditions under which the ultrasonic images were 
obtained. A computer system 21 with automated tracing of echo interfaces and measurements 
of distances between the wall echoes within a 5 mm long section of the brachial artery was 
used. The far wall of the brachial artery was used for measurements of the IMT and lumen 
diameter.  The cross-sectional intima-media area of the brachial artery was calculated using 
the same formula as for the common carotid intima-media area. 
The differences between repeated measurements of IMT and lumen diameter by using the 
automated analysing system, were 3.0 % and 1.4 % (coefficient of variation), respectively.   
Statistical analysis 
Results are reported as mean ± SD except where indicated otherwise. All data analyses were 
done using Statistica for Windows software version 7.0. Mann-Whitney U test, X² test, 
Spearman’s correlation of coefficient and stepwise regression analysis were performed. Since 
coagulations factors were not normally distributed a log transformation were performed. 
Statistical significance was taken at level of P<0.05. 
 Results 
Baseline characteristics of the study are shown in Table 1. Total cholesterol level was 
significantly higher in the control group than in the study group (P<0.01). Prothrombin 
fragment 1+2 and PAI-1 was significantly higher in patients with previous myocardial 
infarction compared to the control group (P<0.001 respectively P< 0.01). Regarding smoking 
habits there were more former smokers and less snuff users in the study group (P<0.05). 
 
Table 2 shows TVI-data between the two groups. Early diastolic filling velocity (E´-v) and 
late diastolic filling peak velocity (A´-v) was significantly lower among patients with 
previous myocardial infarction than in the control group (P<0.01 respectively P<0.001). There 
were no significant differences between the two groups regarding; left ventricle ejection time 
(S2), the mean of isovolumic contraction time (IVCT), the mean of isovolumic relaxation 
time (IVRT) or myocardial performance index (MPI). 
 
Table 3 demonstrates the correlation between late diastolic filling peak time and study 
variables in the two groups. In patients with previous myocardial infarction, late diastolic 
filling peak time was significantly and positively associated with log Prothrombin fragment 
1+2 (P<0.001) and with cIMa of the common carotid and brachial arteries (P<0.05) also 
shown in the figures 1 and 2 respectively. Moreover late diastolic filling peak time correlated 
positively and significantly to systolic blood pressure (P<0.01) and to IMT of brachial artery 
(P<0.02). In the control group, late diastolic filling peak time was significantly and positively 
associated with heart rate (r=0.66) (P<0.04). 
When cIMa of the common carotid and brachial arteries, systolic blood pressure and log 
Prothrombin fragment 1+2 were entered into a stepwise multiple regression analysis, log 
Prothrombin fragment 1+2 remained the only variable with independent significant 
correlation to late diastolic filling peak time, in patients with previous myocardial infarction. 
 
At the time of inclusion 104 (99%) of patients with previous myocardial infarction were 
taking Aspirin, 97 (92%) B-blockers. Statins were given to 97 (92%) patients and 26 (25%) 
received Angiotensin converting enzyme inhibitor.  
Discussion 
The main results of this study are that late diastolic filling peak time is significantly correlated 
to systolic blood pressure, to the level of prothrombin fragment 1+2, to IMT of brachial artery 
and to the cIMA of carotid artery, in patients with a previous history of myocardial infarction. 
Thus, atherosclerosis, diastolic dysfunction and coagulopathy are tightly interrelated disorders 
in patients with myocardial infarction. 
 
We rose the question what an elevated level of prothrombin fragment 1+2 represents. Its half-
time is approximately 90 minutes, which could make it a marker of ongoing coagulation. 
Several studies have found a correlation between elevated plasma levels of prothrombin 
fragment 1+2 and presence and severity of atherosclerosis26,27. However, other studies did not 
find any association between prothrombin fragment 1+2 and the severity of angiographically 
measured8natherosclerosis, or presence of coronary heart disease11,12. 
Lopez et al found a significant elevation in prothrombin fragment 1+2 among elderly, patients 
with acute myocardial infarction, hematologic malignancies and pregnancy. They interpreted 
this as a sign for marked clotting activity28. A review by Fareed stated that the 
hypercoaguable state shown in pregnancy, during which prothrombin fragment 1+2 is 
elevated, may increase the risk for venous thrombosis. However concerning atherosclerosis, 
they claimed that atherosclerosis is associated with vascular dysfunction and may require 
other markers than Prothrombin fragment 1+2. On the other hand, their review suggests that 
prothrombin fragment 1+2 may be used to supervise the treatment of patients with previous 
myocardial infarction29. 
In line with our findings in the present study, Gyöngyösi et al concluded that elevated levels 
of prothrombin fragment 1+2 were related to signs of plaques instability in patients with 
angina and non-ST elevation myocardial infarction. Moreover they declared that biomarkers 
of plasmin activation system might function as non-invasive determinants in high risk 
populations30.  
Páramo et al demonstrated that prothrombin fragment 1+2 is correlated to IMT in subjects 
without clinically explicit atherosclerotic disease. In addition they proposed that by reducing 
the prothrombin fragment 1+2 level this would tentatively reduce the development of 
atherosclerotic disease16. However, in our study we eliminated the effect of IMT among other 
variables in a multistep analysis, resulting in that only the level of prothrombin fragment 1+2 
remained significantly associated with late diastolic filling peak time. To our knowledge there 
has not been any other study examining the correlation between late diastolic filling peak time 
and prothrombin fragment 1+2. We found no associations between late diastolic filling peak 
time and the other measured factors from the coagulation and fibrinolysis system. 
Our study revealed a significant positive relationship between late diastolic filling peak time 
and IMT of brachial artery as well as between late diastolic filling peak time and cIMA of 
carotid artery. This could demonstrate a positive correlation between two atherosclerotic 
markers and diastolic dysfunction. In line with our study Gonzales et al demonstrated that 
patients with ischemic heart disease and patients with carotid stenosis and stroke had higher 
late diastolic peak velocity as well as higher (A/E)-ratio,  early diastolic time, early diastolic 
acceleration and early diastolic deceleration. Both groups were concluded having diminished 
left ventricle compliance compared to a healthy control group. Their study showed that 
patients with ischemic heart disease had more prominent diastolic dysfunction than patients 
with previous stroke and carotid stenosis30. 
Thune and Solomon31 discuss left ventricular diastolic function after myocardial infarction. 
After an episode of myocardial infarction both the active relaxation and the passive filling 
during diastole are affected. The active relaxation is impaired by diminished recoiled 
phenomena among other factors. Moreover left ventricular stiffness is altered depending on 
the degree of the infarction and the remodeling after. The ventricular stiffness is boosted by 
the interstitial edema and fibrosis but dilatation of the heart works against this effect. Another 
cause of diastolic dysfunction is electromechanical dyssynchrony following myocardial 
infarction which may result in segments contracting even in the early filling phase31. 
Eventually preexisting conditions such as diabetes and hypertension worsen the prognosis 
after the infarction31,32. Additionally Jogestrand et al’s study demonstrated,that there are only, 
if any, a week correlation between common carotid IMT or cIMA and the artery stiffness of 
the common carotid artery wall33. Another study revealed that more prominent atherosclerosis 
was required to identify atherosclerotic plaques by determining wall elasticity34. The 
outcomes in these studies are in line with our findings. We observed that diastolic 
dysfunction, diagnosed by TDI, correlates to a hypercoaguable state and subclinical 
atheorsclerosis in the arteries, in patients with previous history of myocardial infarction. 
Moreover in this study we displayed that late diastolic filling peak time was positively related 
to systolic blood pressure. In hypertensive patients Tanaka et al demonstrated that Loasartan 
(Angiotensin II typ 1 receptor blockade) treatment improved diastolic function confirmed by 
TDI. The study revealed that the ratio of early to late diastolic filling for the transmitral flow 
velocity increased after Losartan treatment as the peak systolic and early diastolic myocardial 
velocities and myocardial velocity gradients in the ventricular septum and left ventricle 
posterior wall did. On the other hand,  Zakynthinos et al illustrated that Losartan treatment did 
not affect the diastolic function of the left ventricle (early diastolic filling velocity [E wave], 
late diastolic filling velocity [A wave], ratio of E/A waves, isovolumic relaxation time), which 
were abnormal at baseline. Nevertheless the medication reduced left ventricular hypertrophy 
proportionally to blood pressure35. In our study 25% of the study group were on angiotensin 
converting enzyme inhibitor, this could have influenced the outcome. It is reasonable to 
believe that patients in our study taking this treatment could have shown a stronger correlation 
between systolic blood pressure and late diastolic filling peak time, without the medication. 
Further studies need to explore the correlation between late diastolic filling peak time and 
systolic blood pressure.  
We need to consider some methodological aspects of our study. The study group includes 
patients with previous episodes of myocardial infarction. The disadvantage of such a 
population is that almost all participants will be given medical treatment. Kienast el al 
illustrate that oral anticoagulants was associated with reduced mean level of prothrombin 
fragment 1+2 in patients with angina pectoris8. Patients receiving anticoagulant therapy were 
therefore excluded in our study not to influence the outcome.  
Subjects in the control group had higher levels of cholesterol than the study group. Almost all 
of the patients with previous history of myocardial infarction received statins, which the 
subjects in the control group did not. This could explain the above mentioned finding. A 
correlation that might have been hidden in the study group is the association seen in the 
control group between late diastolic filling peak time and heart rate. The lack of such a 
relation in the study group might be due to the high prevalence of beta-receptor blockage 
treatment (92%) in patients with previous MI. A limitation with this study is the small number 
of subjects in the control group.  Nevertheless the two groups were of comparable age.  
Prospective studies could increase our knowledge of the relationship between diastolic 
dysfunction, a hypercoaguable state, and subclinical atherosclerosis and elevated systolic 
blood pressure in patients with previous history of myocardial infarction. 
In conclusion, we observed a tight correlation between atherosclerosis, diastolic dysfunction 
and coagulopathy in patients with myocardial infarction. 
  
 
1. Bach DS, Armstrong WF, Donovan CL, Muller DW. Quantitative Doppler tissue imaging for 
assessment of regional myocardial velocities during transient ischemia and reperfusion. Am Heart J 
1996;132:721-5. 
2. Severino S, Caso P, Galderisi M, De Simone L, Petrocelli A, de Divitiis O, Mininni N. Use of pulsed 
Doppler tissue imaging to assess regional left ventricular diastolic dysfunction in hypertrophic 
cardiomyopathy. Am J Cardiol 1998;82:1394-8. 
3. Naqvi TZ, Padmanabhan S, Rafii F, Hyuhn HK, Mirocha J. Comparison of usefulness of left 
ventricular diastolic versus systolic function as a predictor of outcome following primary 
percutaneous coronary angioplasty for acute myocardial infarction. Am J Cardiol 2006;97:160-6. 
4. Small M, Lowe GD, Douglas JT, Hutton I, Lorimer AR, Forbes CD. Thrombin and plasmin activity in 
coronary artery disease. Br Heart J 1988;60:201-3. 
5. van der Poll T, Buller HR, ten Cate H, Wortel CH, Bauer KA, van Deventer SJ, Hack CE, Sauerwein 
HP, Rosenberg RD, ten Cate JW. Activation of coagulation after administration of tumor necrosis 
factor to normal subjects. N Engl J Med 1990;322:1622-7. 
6. Bauer KA, Broekmans AW, Bertina RM, Conard J, Horellou MH, Samama MM, Rosenberg RD. 
Hemostatic enzyme generation in the blood of patients with hereditary protein C deficiency. Blood 
1988;71:1418-26. 
7. Agewall S, Wikstrand J, Fagerberg B. Prothrombin fragment 1+2 is a risk factor for myocardial 
infarction in treated hypertensive men. J Hypertens 1998;16:537-41. 
8. Kienast J, Thompson SG, Raskino C, Pelzer H, Fechtrup C, Ostermann H, van de Loo J. Prothrombin 
activation fragment 1 + 2 and thrombin antithrombin III complexes in patients with angina pectoris: 
relation to the presence and severity of coronary atherosclerosis. Thromb Haemost 1993;70:550-3. 
9. Agewall S, Wikstrand J, Suurkula M, Tengborn L, Fagerberg B. Carotid artery wall morphology, 
haemostatic factors and cardiovascular disease. An ultrasound study in men at high and low risk for 
atherosclerotic disease. Blood Coagul Fibrinolysis 1994;5:895-904. 
10. Agewall S, Wikstrand J, Wendelhag I, Tengborn L, Fagerberg B. Femoral artery wall morphology, 
hemostatic factors and intermittent claudication: ultrasound study in men at high and low risk for 
atherosclerotic disease. Haemostasis 1996;26:45-57. 
11. Folsom AR, Aleksic N, Park E, Salomaa V, Juneja H, Wu KK. Prospective study of fibrinolytic factors 
and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. 
Arterioscler Thromb Vasc Biol 2001;21:611-7. 
12. Cooper JA, Miller GJ, Bauer KA, Morrissey JH, Meade TW, Howarth DJ, Barzegar S, Mitchell JP, 
Rosenberg RD. Comparison of novel hemostatic factors and conventional risk factors for prediction of 
coronary heart disease. Circulation 2000;102:2816-22. 
13. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media 
thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 
1997;96:1432-7. 
14. Chambless LE, Folsom AR, Clegg LX, Sharrett AR, Shahar E, Nieto FJ, Rosamond WD, Evans G. 
Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities 
(ARIC) study. Am J Epidemiol 2000;151:478-87. 
15. Longstreth WT, Jr., Shemanski L, Lefkowitz D, O'Leary DH, Polak JF, Wolfson SK, Jr. Asymptomatic 
internal carotid artery stenosis defined by ultrasound and the risk of subsequent stroke in the 
elderly. The Cardiovascular Health Study. Stroke 1998;29:2371-6. 
16. Paramo JA, Orbe J, Beloqui O, Benito A, Colina I, Martinez-Vila E, Diez J. Prothrombin fragment 
1+2 is associated with carotid intima-media thickness in subjects free of clinical cardiovascular 
disease. Stroke 2004;35:1085-9. 
17. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined--a consensus 
document of The Joint European Society of Cardiology/American College of Cardiology Committee 
for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-69. 
18. Gaballa M LB, Storaa C, van der linden J, Brodin L-Å. Intra-and interobsever reproducibility in off-
line extracted cadiac tissue Doppler velocity measurement and drived variables. Prec IEEE. 
Engineering in Medicine and Biology 2001;1(2):4-6. 
19. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek 
N, Sahn D, Schnittger I, et al. Recommendations for quantitation of the left ventricle by two-
dimensional echocardiography. American Society of Echocardiography Committee on Standards, 
Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 
1989;2:358-67. 
20. Owen A. Effect of increasing age on diastolic motion of the left ventricular atrioventricular plane 
in normal subjects. Int J Cardiol 1999;69:127-32. 
21. Wendelhag I, Liang Q, Gustavsson T, Wikstrand J. A new automated computerized analyzing 
system simplifies readings and reduces the variability in ultrasound measurement of intima-media 
thickness. Stroke 1997;28:2195-200. 
22. Jogestrand T NJ, Sylvén, C. Improvement of common carotid intima-media complex 
measurements by calculating the cross-sectional area. J Vasc Invest 1995;4:193-195. 
23. Lemne C, Jogestrand T, de Faire U. Carotid intima-media thickness and plaque in borderline 
hypertension. Stroke 1995;26:34-9. 
24. Nowak J, Nilsson T, Sylven C, Jogestrand T. Potential of carotid ultrasonography in the diagnosis 
of coronary artery disease: a comparison with exercise test and variance ECG. Stroke 1998;29:439-46. 
25. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, 
Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R. Guidelines for the 
ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a 
report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002;39:257-65. 
26. Giannitsis E, Siemens HJ, Mitusch R, Tettenborn I, Wiegand U, Schmucker G, Sheikhzadeh A, 
Stierle U. Prothrombin fragments F1+2, thrombin-antithrombin III complexes, fibrin monomers and 
fibrinogen in patients with coronary atherosclerosis. Int J Cardiol 1999;68:269-74. 
27. De Buyzere M, Philippe J, Duprez D, Baele G, Clement DL. Coagulation system activation and 
increase of D-dimer levels in peripheral arterial occlusive disease. Am J Hematol 1993;43:91-4. 
28. Lopez Y, Paloma MJ, Rifon J, Cuesta B, Paramo JA. Measurement of prethrombotic markers in the 
assessment of acquired hypercoagulable states. Thromb Res 1999;93:71-8. 
29. Gonzalez Romero S, Asin Cardiel E, Cobos MA. [A study of left ventricle filling using pulsed 
Doppler in patients with a high prevalence of atherosclerosis]. Arch Inst Cardiol Mex 1989;59:493-7. 
30. Gyongyosi M, Glogar D, Weidinger F, Domanovits H, Laggner A, Wojta J, Zorn G, Iordanova N, 
Huber K. Association between plasmin activation system and intravascular ultrasound signs of plaque 
instability in patients with unstable angina and non-st-segment elevation myocardial infarction. Am 
Heart J 2004;147:158-64. 
31. Thune JJ, Solomon SD. Left ventricular diastolic function following myocardial infarction. Curr 
Heart Fail Rep 2006;3:170-4. 
32. Estep JD, Aguilar D. Diabetes and heart failure in the post-myocardial infarction patient. Curr 
Heart Fail Rep 2006;3:164-9. 
33. Jogestrand T, Eiken O, Nowak J. Relation between the elastic properties and intima-media 
thickness of the common carotid artery. Clin Physiol Funct Imaging 2003;23:134-7. 
34. Labropoulos N, Ashraf Mansour M, Kang SS, Oh DS, Buckman J, Baker WH. Viscoelastic properties 
of normal and atherosclerotic carotid arteries. Eur J Vasc Endovasc Surg 2000;19:221-5. 
35. Zakynthinos E, Pierutsakos C, Konstantinidis K, Zakynthinos S, Papadogiannis D. Losartan reduces 
left ventricular hypertrophy proportionally to blood pressure reduction in hypertensives, but does 
not affect diastolic cardiac function. Angiology 2004;55:669-78. 
 
 
 
 
Table 1. Baseline characteristics of the study subjects. 
 
 
*P<0.05, ** P< 0.01, *** P< 0.001 Mann Whitney test,† P<0.05, †† P< 0.01 X² test. 
 
Patients with previous MI 
N = 105 
Controller 
N = 10 
Age (years) 58± 9 54 ± 12 
Systolic blood pressure (mmHg) 137 ± 20 129 ± 15 
Diastolic blood pressure (mmHg) 80 ± 10 78 ± 5 
Heart rate (bpm) 58 ± 10 61 ± 13 
Total cholesterol (mmol/L) 4.7 ± 0.8** 5.5 ± 0.8 
Triglycerides (mmol/L) 1.7 ± 1.1 1.1 ± 0.3 
Fasting plasma glucose (mmol/l) 5.4 ± 1.4 5.2 ± 0.4 
BMI (kg/m²) 27 ± 4.0 26 ± 3 
Ejection fraction (%) 53 ± 9.0 52 ± 5 
Prothrombin fragment 1+2 (nmol/l) 0.9 ± 0.8*** 0.5 ± 0.2 
von Willebrand factor (IU/ml) 1.32 ± 0.43  1.2 ± 0.37 
Plasminogen activator inhibitor 1 activity (IU/ml) 20.2 ± 18.2**   7.58 ± 6.63 
Fibrinogen (g/l) 3.3 ± 0.7 3.10 ± 0.65 
Hs-CRP, mg/l 3.1 ± 4.90 1.50 ± 1.78 
Calculated brachial intima media area (mm²)   5.0 ± 1.5 5.0 ± 2.0 
Calculated carotid intima-media area, mean (mm2) 18± 5 15 ± 4 
Smoking habits, n (%)   
Current smoker 20 (19)  2 (20) 
Never smoked 19 (18) 4 (40) 
Prior smoker 62 (59) †           2 (20) 
Snuff user 4 (4) † 2 (20) 
 Table 2- Tissue Doppler imaging (TDI) data of patients with cardiovascular disease (CVD) and 
control group. 
TDI data CVD group N = 105 Control group N = 10 
S2 (ms) 298 ± 30 296 ± 21 
E'-v (cm/s) -5.8 ± 2.0** -7.7 ± 2.0 
A'-v (cm/s) -6.3 ± 2.0*** -8.9 ± 1.1 
E'/A' 1.0 ± 0.4  0.9 ± 0.3 
E' -T (ms)  189 ± 35 177 ± 21 
A' -T (ms) 120 ± 18 123 ± 18 
IVRT (ms) 96 ± 24 86 ± 36 
IVCT mean  71 ± 18 73 ± 13 
MPI  0.6 ± 0.1 0.5 ± 0.2 
*P<0.05, ** P< 0.01, *** P< 0.001 Mann Whitney test. S systole, V indicates velocity, E'-v early diastolic filling 
peak velocity,  
A'-v late diastolic filling peak velocity, E'/A' ratio of the early to late peak diastolic velocity.  E' –T early 
diastolic filling time,  
A' –T late diastolic filling time.  IVRT isovolemic relaxation time. IVCT  isovolemic contraction time. MPI 
myocardial performance index. 
 
 
 Table -3 Correlation coefficients between late diastolic filling time and variables in focus. 
 CVD group (n=105) Control group (n=10) 
R P-value R P-value 
Age (years) -0.02 0.88 0.36 0.34 
Systolic blood pressure (mmHg) 0.26 0.01 0.47 0.20 
Diastolic blood pressure (mmHg) 0.00 1.0 -0.20 0.60 
Heart rate (bpm)  -0.14 0.16 0.66 0.04 
Total cholesterol (mmol/l) 0.03 0.80 -0.28 0.49 
Triglycerides (mmol/l) -0.06 0.58 -0.30 0.44 
Fasting plasma glucose (mmol/l) -0.10 0.31 -0.41 0.28 
BMI (kg/m²) 0.03 0.78 -0.30 0.43 
Ejection fraction (%) (Simpson) -0.08 0.47 0.77 0.01 
Log Prothrombin  Fragment 1+2 (nmol/l) 0.37 0.001 -0.12 0.75 
von Willebrand factor (IU/ml) -0.14 0.18 0.79 0.01 
Plasminogen activator inhibitor 1 activity (IU/ml) -0.08 0.43 0.13 0.97 
Fibrinogen (g/l) -0.17 0.10 0.36 0.30 
Hs-CRP, mg/l -0.07 0.50 0.37 0.29 
Calculated common carotid intima media area, mm² (mean of right and left side) 0.24 0.02 0.49 0.18 
Calculated brachial artery intima media area (mm²)   0.23 0.02 0.20 0.59 
CVD, cardiovascular disease, CRP, High sensitivity C-reactive protein  
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 Figure-2 
R= 0.24, P<0.05
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